Corrigendum to “Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1”

Corrigendum to “Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1”

Bibliographic Details
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	Molecular Therapy: Nucleic Acids
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253117300227

Similar Items

Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
by: Tobias Bonifert, et al.
Published: (2016-01-01)

Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation
by: Anna-Lena Panagiotopoulos, et al.
Published: (2020-09-01)

Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation
by: Radulfus WN Slijkerman, et al.
Published: (2016-01-01)

Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript
by: Loren L. Flynn, et al.
Published: (2018-06-01)

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
by: May T. Aung-Htut, et al.
Published: (2019-10-01)

Restoration of the normal splicing pattern of the PLP1 gene by means of an antisense oligonucleotide directed against an exonic mutation.
by: Stefano Regis, et al.
Published: (2013-01-01)

Restoration of correct splicing in IVSI-110 mutation of β-globin gene with antisense oligonucleotides: implications and applications in functional assay development
by: Sima Mansoori Derakhshan, et al.
Published: (2017-06-01)

Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
by: Saskia Breuel, et al.
Published: (2019-12-01)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
by: Zhenxun Wang, et al.
Published: (2012-01-01)

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
by: Kristin A. Ham, et al.
Published: (2021-07-01)

Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations
by: Lorenzo Ferri, et al.
Published: (2016-01-01)

Corrigendum to “From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides”
Published: (2016-01-01)

Antisense Oligonucleotide Screening to Optimize the Rescue of the Splicing Defect Caused by the Recurrent Deep-Intronic <i>ABCA4</i> Variant c.4539+2001G>A in Stargardt Disease
by: Alejandro Garanto, et al.
Published: (2019-06-01)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish.
by: Andrea Pauli, et al.
Published: (2015-01-01)

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
by: Kian Huat Lim, et al.
Published: (2020-07-01)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
by: Kole Ryszard, et al.
Published: (2011-10-01)

Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy
by: Liliana Matos, et al.
Published: (2018-09-01)

A Sensitive Assay System To Test Antisense Oligonucleotides for Splice Suppression Therapy in the Mouse Liver
by: Lorena Gallego-Villar, et al.
Published: (2014-01-01)

Antisense oligonucleotides in neurological disorders
by: Claudia D. Wurster, et al.
Published: (2018-05-01)

Data in support of a functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II
by: Liliana Matos, et al.
Published: (2015-12-01)

Antisense Oligonucleotide-Based Splicing Correction in Individuals with Leber Congenital Amaurosis due to Compound Heterozygosity for the c.2991+1655A>G Mutation in CEP290
by: Lonneke Duijkers, et al.
Published: (2018-03-01)

Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease
by: Erik van der Wal, et al.
Published: (2017-06-01)

Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52
by: Jessica M. Cale, et al.
Published: (2021-03-01)

Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases
by: Xinye Qian, et al.
Published: (2021-03-01)

Correction: A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.
by: Dorota Magner, et al.
Published: (2016-01-01)

Oligonucleotide–Palladacycle Conjugates as Splice-Correcting Agents
by: Madhuri Hande, et al.
Published: (2019-03-01)

Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo
by: Safa Bazaz, et al.
Published: (2021-08-01)

Inhibition of leukemic apoptosis by antisense oligonucleotide.
Published: (1995)

Selective targeting of MYC by antisense oligonucleotides
by: Gill, Taylor Elizabeth
Published: (2018)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles
by: Birgit Spänkuch, et al.
Published: (2008-03-01)

A Homozygous Deep Intronic Mutation Alters the Splicing of Nebulin Gene in a Patient With Nemaline Myopathy
by: Nathalie Laflamme, et al.
Published: (2021-06-01)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
by: Peter Järver, et al.
Published: (2012-01-01)

Peptide-mediated delivery of antisense oligonucleotides and chemotherapeutics across biological barriers
by: Fadzen, Colin MacLaine
Published: (2018)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
by: Marc Gotkine, et al.
Published: (2015-01-01)

Modulation of dystrophin pre-mRNA splicing by antisense oligonucleotides : a potential therapy for Duchenne muscular dystrophy
by: Thorogood, Francesca Clare
Published: (2007)

LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts
by: Aleksander Touznik, et al.
Published: (2017-06-01)

NOVEL intronic CAPN3 Roma mutation alters splicing causing RNA mediated decay
by: Fabiola Mavillard, et al.
Published: (2019-11-01)

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
by: Joanna A. Korecka, et al.
Published: (2020-09-01)